Baylor College Of Medicine

We track 3 ClinicalTrials.gov studies led by Baylor College Of Medicine. The portfolio skews toward Phase 1 (3 trials).

3 clinical trials sponsored by Baylor College Of Medicine.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 3
100%

Trial Status Breakdown

Trials by Baylor College Of Medicine

Robust Armored Dual-Cytokine (IL-15/IL-21) GPC3-CAR T Cells for Atypical Teratoid Rhabdoid Tumors and Central Nervous System Rhabdoid Tumors (RADIANT)

NCT07513194 · NOT YET RECRUITING · Phase 1

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressing Autologous T Cells as an Immunotherapy for Children With Solid Tumors (CARE)

NCT04715191 · RECRUITING · Phase 1

Autologous Activated T-Cells Transduced With A 3rd Generation GD-2 Chimeric Antigen Receptor And iCaspase9 Safety Switch Administered To Patients With Relapsed Or Refractory Neuroblastoma (GRAIN)

NCT01822652 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

How many clinical trials does Baylor College Of Medicine sponsor?

Baylor College Of Medicine currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 1.

What conditions does Baylor College Of Medicine research?

Baylor College Of Medicine conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Baylor College Of Medicine recruiting for clinical trials?

Yes, Baylor College Of Medicine currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More